Table 2.
Type of Vaccine Administered by Age in 2009*
| Type of Vaccine |
Age Category # (%) |
|||||
|---|---|---|---|---|---|---|
| <2 | 2-5 | 6-17 | 18-44 | 45-64 | >65 | |
| Influenza** | 2,762 (0.2) | 8,8715 (4.9) | 24,0375 (13.2) | 441,796 (24.2) | 568,448 (31.1) | 484,595 (26.5) |
| Pneumococcal | - | 774 (1.3) | 1,805 (3.1) | 7,861 (13.3) | 20,776 (35.2) | 27,727 (47.0) |
| Meningitis | - | - | 1,721 (36.8) | 2,685 (57.4) | 230 (4.9) | - |
| Tetanus- containing vaccine^ |
97 (0.3) | 7,473 (22.3) | 15,497 (46.2) | 7,923 (23.6) | 2,570 (7.7) | |
| Hepatitis A | - | 86 (2.7) | 307 (9.5) | 1603 (49.6) | 997 (30.9) | 239 (7.4) |
| Hepatitis B | - | 21 (0.2) | 457 (4.1) | 7041 (63.5) | 3113 (28.1) | 452 (4.1) |
| Measles, mumps, and rubella |
92 (2.1) | 325 (7.3) | 3,331 (74.8) | 668 (15.0) | 38 (0.9) | |
*
Table reports data from the two largest retail clinic operators (representing 76% of all retail clinics in the U.S.) These clinics supplied both CPT codes and diagnosis codes to the study team.
**
Includes both seasonal and H1N1 vaccinations
^
Tetanus-containing vaccines include tetanus and diphtheria toxoids (Td) vaccine or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.